Unknown's avatar

About Glyn and Liz

Writer Liz wainwright and Independent Researcher Glyn Wainwright

Link

/* Style Definitions */
table.MsoNormalTable
{mso-style-name:”Table Normal”;
mso-tstyle-rowband-size:0;
mso-tstyle-colband-size:0;
mso-style-noshow:yes;
mso-style-priority:99;
mso-style-qformat:yes;
mso-style-parent:””;
mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
mso-para-margin-top:0cm;
mso-para-margin-right:0cm;
mso-para-margin-bottom:10.0pt;
mso-para-margin-left:0cm;
line-height:115%;
mso-pagination:widow-orphan;
font-size:11.0pt;
font-family:”Calibri”,”sans-serif”;
mso-ascii-font-family:Calibri;
mso-ascii-theme-font:minor-latin;
mso-fareast-font-family:”Times New Roman”;
mso-fareast-theme-font:minor-fareast;
mso-hansi-font-family:Calibri;
mso-hansi-theme-font:minor-latin;}

Over the 40 years from 1969 to 2009, I had a forty year anecdotal adventure in biochemistry leading to the publication of a seminal paper on cell-membranes and an invitation to contribute more biochemical thoughts in new hypotheses about modern medicine.  12 years involved in teaching chemistry followed by 28 years in Information technology.

image

Normal
0

false
false
false

EN-GB
X-NONE
X-NONE

MicrosoftInternetExplorer4

The anecdotal adventures in biochemistry started in the 1970s. Working as a chemistry teacher I found myself increasingly troubled by contact dermatitis and eczema.   This career trauma led to my retraining as a computer scientist and information technologist, a cleaner environment in which to survive and explore modern science.

The Anecdotal Biochemist

Link

There is NO evidence that in an otherwise healthy person measuring blood cholesterol and taking a statin to lower blood cholesterol will live any longer than not doing so. Even the Canadian Government in allowing the publication of these ads swallowed the big lie.

All primary prevention trials to date of cholesterol lowering with drugs (LRC-CPPT, WOSCOPS, ASCOT-LLA) have shown NO total mortality benefit.  But they keep trying to sell the red rice yeast toxins etc…

Don’t believe the claims of the manufacturers!

Link

Fructose is the most potent inhibitor  (after cholesterol) of copper utilization discovered, to date. It has been known since the 30s that copper deficiency impairs glucose tolerance;

Metabolic interactions among dietary cholesterol, copper, and fructose

doi:10.1152/ajpendo.00591.2009

Leslie M. Klevay
Departments of Internal Medicine and of Pharmacology, Physiology, and Therapeutics, University of North Dakota, School of Medicine and Health Sciences, Grand Forks, North Dakota

Global High Fructose Corn Syrup Use May Be Fueling Diabetes Increase

Link

Fighting the flab means fighting makers of fatty foods -WRONG !!!  – New Scientist Opinion Column

My response to this article in New Scientist this week:-

Carbohydrates and insulin are obesogenic and dietary fats are not obesogenic.

The Danish politicians who taxed fat were the victims of erroneous medical advice.

Sugar causes obesity, and we explain further in our research review paper:

Is the metabolic syndrome caused by a high fructose, and relatively low fat, low cholesterol diet?

Seneff S, Wainwright G, Mascitelli L.

Arch Med Sci. 2011 Feb;7(1):8-20 Epub 2011 Mar 8.

doi: 10.5114/aoms.2011.20598

PMCID: PMC3258689

Dietary Fats are not Obesogenic – Sugar does it!

Link

Quoting from Saudi Gazette Report from King of Organs Heart Conference in Hofuf:

The overall impression that evolved from the presentations was summed up in the words of Dr. Malcom Kendrik, “The whole cholesterol thing is bunk”.

King of Organs Conference - Saudi Arabia

Brothers in arms in the assault on the shibboleths of commercial medicine exchange views during a break in proceedings at the King of Organs conference in Hofuf on Tuesday. (L-R) David Diamond, Malcom Kendrick, Carlos Monterio and Paul Rosch. — SG photo

“Dark chocolate is a far better drug to take than statins” David Diamond.

Link

Fat and cholesterol are good for you -see Zoe’s blog for details.

Graph from WHO data

WHO data on Fats (Female) ZH

Zoe Harcombe:

All you need to do is to look at the lines going down to the right and wonder how on earth we ever got away with telling people that cholesterol causes heart disease. High cholesterol is associated with lower heart disease and vice versa – for all the data available in the world. High cholesterol is not even associated with high heart disease, let alone does it cause it.

WHO Cholesterol data

Cholesterol & heart disease – there is a relationship, but it’s not what you think

Fats, Carbohydrates and Proteins

Deprive yourself: The real benefits of fasting

Emma Young – New Scientist 14 November 2012

THERE’S a fuzz in my brain and an ache in my gut. My legs are leaden and my eyesight is blurry. But I have only myself to blame. Besides, I have been assured that these symptoms will pass. Between 10 days and three weeks from now, my body will adjust to the new regime, which entails fasting for two days each week. In the meantime, I just need to keep my eyes on the prize. Forget breakfast and second breakfast, ignore the call of multiple afternoon snacks, because the pay offs of doing without could be enormous.

What about Low-Carb Hi-Fat instead?

The above quote come from a New Scientist which article covers the same Eat, Fast and Live Long territory of recent BBC TV programme.  It looks as though they have not shed much light in this research due to the same popular pre-conceptions and misconceptions about LDLs.

The usual erroneous use of ‘bad’ cholesterol in association with Low-density lipoprotein hardly is a common error. Although raised blood LDL is associated with heart disease it is not the cause.  The cause is sugar damage to the LDL label which prevents it delivering its payload of fats and fat soluble nutrition to the fat-starved organs of the body. The brain needs huge amounts.

The common medical response to our vital organs being LDL starved is to reduce our fat intake. What they should be doing is preventing the sugar-damage to LDL labels allowing our organs to recognise and consume the LDL associated nutrients.

This is what happens when association of LDL with disease is confused with causation. A complete farce which has blinded medical science for 50 years and more!

Eating carbohydrates will generate sugar which insulin will convert into fat.

Eating proteins instead will generate damaging oxides of nitrogen.

Eating fat makes good sense and will not make you fat.

Low-Carb High-Fat diets achieve what fasting achieves without the same hunger!

Link

MHRA Drug Safety Update Summary
Statin use may be associated with a level of hyperglycaemia in some patients where formal diabetes care is appropriate. The risk appears to be mainly in patients already at increased risk of developing diabetes. However, the overall benefits of statins strongly outweigh any risks, including in those at risk of developing diabetes or those with pre-existing diabetes

The explanation for this is probably the fact that a 10% depletion in cell-membrane cholesterol will cause pancreatic beta cell to stop all insulin release

Xia F, Xie L, Mihic A, et al. Inhibition of cholesterol biosynthesis impairs insulin secretion and voltage-gated calcium channel function in pancreatic beta-cells. Endocrinology 2008; 149: 5136-45.

Statins: risk of hyperglycaemia and diabetes

Link

MHRA Drug Safety Update Summary

In August 2012 we published advice that simvastatin is now contraindicated with concomitant use of certain medicines, such as ciclosporin, danazol, and gemfibrozil. In addition, the recommendations for the maximum dose of simvastatin have changed when used with a number of other medicines, including amlodipine and diltiazem. These changes were driven primarily by concerns about an increased risk of myopathy and/or rhabdomyolysis at higher plasma concentrations of simvastatin, which may result from such drug interactions.

Following further consideration by the Pharmacovigilance Expert Advisory Group of the Commission on Human Medicines, this article summarises the evidence underlying the new advice that the maximum recommended dose for simvastatin in conjunction with amlodipine and diltiazem is now 20 mg/day. The prescribed doses of amlodipine and diltiazem need not be changed.

MHRA Drug Safety Update – Statin

Link

Myopathy is a known side effect of all statins, including simvastatin, and the risk increases with higher doses. However, its most serious form, rhabdomyolysis, is a very rare side effect. The risk of myopathy is greater in: elderly patients (>65 years); women; patients with renal impairment or hypothyroidism; patients who consume large quantities of alcohol; those with a history of previous muscle problems during treatment with statins or other lipid-lowering drugs; or those with family history of muscle disorders. Concomitant use of some medicines may also increase the risk of muscle damage.

Statins MHRA warning

UK GPs warned over muscle risk with Statin